Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Study to Assess the Safety and Efficacy of the Novel Noninvasive Hypersound Neuromodulation System in the Treatment of Patients With Chronic Pain of Peripheral Nerve Origin, Including Neuropathy, Sciatica, and Joint Pain

NCT06626854 is registered in ClinicalTrials.gov with Hypersound Medical Inc as lead sponsor.

NCT NCT06626854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06626854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Study to Assess the Safety and Efficacy of the Novel Noninvasive Hypersound Neuromodulation System in the Treatment of Patients With Chronic Pain of Peripheral Nerve Origin, Including Neuropathy, Sciatica, and Joint Pain
Lead sponsor
Hypersound Medical Inc
Phase
Phase 1
Overall status
Not yet recruiting
Start date
June 10, 2026
Completion date
December 10, 2026
Enrollment
5 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic knee osteoarthritis, chronic knee pain, post surgical neuropathic pain